The table below shows PROCEPT BioRobotics Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$48.98M
-$99.21M
-$108.00M
-$80.38M
-$57.33M
-$48.34M
Capital expenditure
$9.36M
$4.41M
$25.21M
$2.65M
$592.00K
$233.00K
Investing cash flow
-$9.36M
-$4.41M
-$25.21M
-$2.65M
-$592.00K
-$233.00K
Dividends paid
-
-
-
-
PRCT operating cash flow (10-K history)
PROCEPT BioRobotics Corp reported operating cash flow of -$48.98M for fiscal year 2025. That is up 50.6% from -$99.21M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$48.34M (FY 2020) to -$48.98M. Figures come from the company's audited annual reports as filed with the SEC.